Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Lal

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|January 10, 2015
Innate sensing of microbial products promotes wound-induced skin cancerEsther Hoste, Esther N Arwert, Rohit Lal, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Anticancer Research|July 3, 2017
Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung CancerGiuseppe L Banna, Hector Josè Soto Parra, Marine Castaing, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapySophie Papa, Sanjay Popat, Riyaz Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapySiow Ming Lee, Sunil Upadhyay, Conrad Lewanski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2013
First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumorsAndré T Brunetto, Joo Ern Ang, Rohit Lal, et al.
The Lancet. Oncology|October 20, 2012
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trialSiow Ming Lee, Iftekhar Khan, Sunil Upadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studiesTimothy A Yap, Hendrik-Tobias Arkenau, D Ross Camidge, et al.
Scientific Data|March 2, 2026
SuryaBench: Benchmark Dataset for Advancing Machine Learning in Heliophysics and Space Weather PredictionSujit Roy, Dinesha V Hegde, Johannes Schmude, et al.
The Plant Journal : for Cell and Molecular Biology|April 12, 2022
A Solanum lycopersicoides reference genome facilitates insights into tomato specialized metabolism and immunityAdrian F Powell, Ari Feder, Jie Li, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|January 10, 2015
Innate sensing of microbial products promotes wound-induced skin cancerEsther Hoste, Esther N Arwert, Rohit Lal, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Anticancer Research|July 3, 2017
Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung CancerGiuseppe L Banna, Hector Josè Soto Parra, Marine Castaing, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapySophie Papa, Sanjay Popat, Riyaz Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapySiow Ming Lee, Sunil Upadhyay, Conrad Lewanski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2013
First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumorsAndré T Brunetto, Joo Ern Ang, Rohit Lal, et al.
The Lancet. Oncology|October 20, 2012
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trialSiow Ming Lee, Iftekhar Khan, Sunil Upadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studiesTimothy A Yap, Hendrik-Tobias Arkenau, D Ross Camidge, et al.
Scientific Data|March 2, 2026
SuryaBench: Benchmark Dataset for Advancing Machine Learning in Heliophysics and Space Weather PredictionSujit Roy, Dinesha V Hegde, Johannes Schmude, et al.
The Plant Journal : for Cell and Molecular Biology|April 12, 2022
A Solanum lycopersicoides reference genome facilitates insights into tomato specialized metabolism and immunityAdrian F Powell, Ari Feder, Jie Li, et al.
Pageof 3